AfGin Pharma
AfGin Pharma is a biopharmaceutical research and development company focused on topical delivery of neuro-active drugs via peripheral nerve pathways to access central nervous system targets. The company develops and commercializes topical formulations, pursues preclinical and clinical development, and maintains an intellectual property portfolio across multiple jurisdictions.
Industries
Nr. of Employees
small (1-50)
Products
Topical migraine formulation (consumer topical product)
A topical formulation intended for migraine symptom relief, distributed for consumer use across multiple U.S. states.
Topical migraine formulation (consumer topical product)
A topical formulation intended for migraine symptom relief, distributed for consumer use across multiple U.S. states.
Services
Support for preclinical and clinical advancement of topical formulations targeting neurological indications.
Development and management of patent filings and portfolio strategy with access to specialized patent counsel.
Bringing topical migraine formulation to consumer markets and operating related subsidiaries for market deployment.
Support for preclinical and clinical advancement of topical formulations targeting neurological indications.
Development and management of patent filings and portfolio strategy with access to specialized patent counsel.
Bringing topical migraine formulation to consumer markets and operating related subsidiaries for market deployment.
Expertise Areas
- Topical neuroactive drug delivery
- Clinical development and investigator-led studies
- Neurology and neuropsychiatry therapeutic areas
- Formulation development and compounding for topical products
Key Technologies
- Topical nerve-targeted drug delivery
- Peripheral nerve pathway CNS targeting
- Topical formulation development for neuro-active agents
- Investigator-led clinical trial conduct
News & Updates
Publication related to topical drug delivery for migraine (PDF).
Publication referencing topical drug delivery (PDF).
Publication on diabetic peripheral neuropathy and topical delivery (PDF).
Patents related to the topical neuro-active delivery technology have been granted by USPTO, EU and Australian patent offices; additional patents filed and pending.
Publication related to topical drug delivery for migraine (PDF).
Publication referencing topical drug delivery (PDF).
Publication on diabetic peripheral neuropathy and topical delivery (PDF).
Patents related to the topical neuro-active delivery technology have been granted by USPTO, EU and Australian patent offices; additional patents filed and pending.